All lobbying filings

ALBEMARLE CORPORATION

Lobbying for ALBEMARLE CORPORATION · Specialty Chemical manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $630,000.00 expenses · posted Jul 18, 2025

Official filing document

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 4016
Department of Defense Appropriations Act, 2026

Lobbying activity 6

Taxation/Internal Revenue Code

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

Foreign Relations

Issues related to trade and mineral supply

Manufacturing

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

Defense

H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law No: 119-4); H.R.4016, Department of Defense Appropriations Act, 2026; issues related to lithium batteries

Natural Resources

Issues related to critical minerals development and oil field brine lithium development (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

Trade (domestic/foreign)

Issues related to mineral supply (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.